The Sweden-based drug firm Recipharm has entered into an agreement to acquire a majority stake in Nitin Lifesciences Ltd, a sterile injectable company, for an estimated Rs 671.2 crore.“Reci…
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
